ARTICLE | Clinical News
Aubagio teriflunomide regulatory update
December 3, 2012 8:00 AM UTC
Australia's Therapeutic Goods Administration ( TGA) approved once-daily, oral Aubagio teriflunomide from Sanofi to treat relapsing forms of multiple sclerosis (MS). The pharma said Aubagio is now mark...